Exelixis, Inc. (EXEL) Presents at Leerink Global Healthcare Conference 2026 Transcript [Seeking Alpha]
Exelixis, Inc. (EXEL)
Last exelixis, inc. earnings: 2/25 04:05 pm
Check Earnings Report
US:NASDAQ Investor Relations:
ir.exelixis.com/phoenix.zhtml?c=120923&p=irol-mediaresources
Company Research
Source: Seeking Alpha
Andrew Peters - Senior Vice President of Strategy Conference Call Participants Emily Kate Shutman - Leerink Partners LLC, Research Division Presentation Emily Kate Shutman Leerink Partners LLC, Research Division Good morning, everyone. My name is Emily Shutman, I'm a Vice President here on the Targeted Oncology team at Leerink. And I'm super happy to have with me Andrew Peters, Senior Vice President of Strategy and Investor Relations at Exelixis. So thanks so much for being with us today. Andrew Peters Senior Vice President of Strategy Happy to be here. Question-and-Answer Session Emily Kate Shutman Leerink Partners LLC, Research Division Great. So yes, maybe we could start out. ASCO GU happened very recently. So I was thinking we could start with RCC and talk about some of the dynamics within the HIF-2 alpha space for RCC. The results from LITESPARK-011 for belzutifan and Lenvima and second-line RCC were just presented. I believe it showed a PFS benefit wit
Show less
Read more
Impact Snapshot
Event Time:
EXEL
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
EXEL alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
EXEL alerts
High impacting Exelixis, Inc. news events
Weekly update
A roundup of the hottest topics
EXEL
News
- Exelixis (EXEL) was upgraded by Truist Financial Corporation to "strong-buy".MarketBeat
- Exelixis (EXEL) Valuation After Earnings Beat FDA Progress And Cabometyx Label Expansion [Yahoo! Finance]Yahoo! Finance
- Exelixis Highlights Zanzalintinib RCC Trials, Sequencing Debate, and December CRC PDUFA at Leerink [Yahoo! Finance]Yahoo! Finance
- Exelixis Highlights CABOMETYX Growth, Zanzalintinib PDUFA and Pipeline Strategy at Barclays Conference [Yahoo! Finance]Yahoo! Finance
- Exelixis Highlights $2.4B 2026 Outlook, Cabometyx Momentum and Zanzalintinib Catalysts at Conference [Yahoo! Finance]Yahoo! Finance
EXEL
Earnings
- 2/10/26 - Beat
EXEL
Sec Filings
- 3/26/26 - Form SCHEDULE
- 3/2/26 - Form 4
- 3/2/26 - Form 4
- EXEL's page on the SEC website